News Releases - 2010

21 DEC 2010　[Pharmaceuticals]

• Starting co-promotion of the anti-cancer agent “SPRYCEL^® Tablet 20mg and SPRYCEL^® Tablet 50mg” (dasatinib) in Japan

17 DEC 2010　[Pharmaceuticals]

• The results of a subset analysis of Japanese patients from the DASISION trial comparing SPRYCEL^® (dasatinib) with imatinib in the treatment of newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia.

16 DEC 2010　[Corporate]

• Defendants Appeal From Final Judgment in U.S. Abilify^® Patent Litigation

10 DEC 2010　[Pharmaceuticals]

• World's First Aquaretic Agent for the Treatment of Volume Overload in Patients with Heart Failure Samsca^® Tablets 15mg (tolvaptan), Vasopressin V₂-Receptor Antagonist, to be Launched in Japan on December 14

9 DEC 2010　[Corporate]

• Tokushima Itano Factory Recognized Among "Corporate Greening Linked to Conservation of Biodiversity: Best 100" Sole factory manufacturing medical-use pharmaceuticals to receive recognition

7 DEC 2010　[Pharmaceuticals]

• Follow-Up Results from Study Comparing SPRYCEL^® (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Demonstrate Improved Response Rates Consistent with 12 Month Data

19 NOV 2010　[Corporate]

• Toward a Factory that is Friendly to Both the Environment and People the Tokushima Itano Factory Helps to Support the Asan Earth Festival in Itano to be Held on November 23, 2010

18 NOV 2010　[Pharmaceuticals]

• Otsuka Pharmaceutical Files Application in Japan for Additional Indication of L-Cartin^® Tablets for Carnitine Deficiency, Based on Evidences in Public Domain

16 NOV 2010　[Corporate]

• Otsuka Prevails in U.S. Abilify^® Patent Litigation

11 NOV 2010　[Consumer Products]

• Clinical tests in Japan demonstrate research results relating to the efficacy of "Ion supply drink" for dehydration after bathing

9 NOV 2010　[Pharmaceuticals]

• Otsuka Pharmaceutical Files for Regulatory Approval in Japan for Mucosta^® Ophthalmic Suspension for Dry Eye

1 NOV 2010　[Pharmaceuticals]

• FDA Approves SPRYCEL^® (dasatinib) as Treatment for Adult Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia in Chronic Phase

27 OCT 2010　[Pharmaceuticals]

• SAMSCA^™ Tablets 15mg (tolvaptan), Vasopressin V₂-Receptor Antagonist, Receive Regulatory Approval in Japan

25 OCT 2010　[Consumer Products]

• New Release of Medicated Skin Wash in 500mL Pump-style Economy Size and Refill Pouch Available from November 12, 2010

6 OCT 2010　[Pharmaceuticals]

• Otsuka Announces Phase 3 Aripiprazole Intramuscular (IM) Depot Trial Interim Analysis Reveals Efficacy Criteria Met

5 OCT 2010　[Corporate]

• OTSUKA OPENS FIRST OFFICE IN CANADA Important Milestone for Growing North American Pharmaceutical Operations

29 SEP 2010　[Consumer Products]

• Tweet Runners app for iPhone released on September 29^th Tweet Runners and Amino-Value keep runners going

27 SEP 2010　[Pharmaceuticals]

• Otsuka Pharmaceutical and Acucela Enter New Co-Development and Co-Promotion Agreement for OPA-6566 for Glaucoma

17 SEP 2010　[Pharmaceuticals]

• Antiepileptic Drug 'E Keppra^® Tablet' with New Mechanism of Action Released on September 17

13 SEP 2010　[Pharmaceuticals]

• The Antiplatelet Agent Pletaal^® (Nonproprietary Name: Cilostazol) The Results of CSPS 2, a Large-Scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Posted on the Online Version of The Lancet Neurology

8 SEP 2010　[Consumer Products]

• Renewed Package Design for Nature Made America’s number one-selling vitamin, mineral and supplement brand

1 SEP 2010　[Corporate]

• Construction of 'OPS-5', New Plant to Manufacture Active Pharmaceutical Ingredients in Saga Factory Completed on September 1

31 AUG 2010　[Corporate]

• Publication of Environmental and Social Report 2010 - Featuring approaches to help build a low-carbon, recycling-oriented society, development of environment-conscious products and social action programs -

16 AUG 2010　[Corporate]

• 21st Annual Outdoor Concert Held at Otsuka Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki '10 on August 13, 2010

23 JUL 2010　[Pharmaceuticals]

• E Keppra^® (levetiracetam) receives regulatory approval in Japan

14 JUL 2010　【Consumer Products】

• Care for delicate neck and decolletage areas InnerSignal Rejuvenate Clear-up Mask debuts September 1, 2010

12 JUL 2010　[Pharmaceuticals]

• SPRYCEL^® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase

30 JUN 2010　[Corporate]

• GW and Otsuka Agree Three Year Extension to Global Cannabinoid Research Collaboration

14 JUN 2010　[Pharmaceuticals]

• Otsuka receives approval for Rapirun^® H. Pylori Antibody Stick as in vitro diagnostic device on June 8, 2010

10 JUN 2010　[Corporate]

• Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors (PDF:39KB)

9 JUN 2010　[Pharmaceuticals]

• Four-Year Follow-Up Data for SPRYCEL^® (dasatinib) Demonstrate 82 Percent Overall Survival in Patients with Chronic Myeloid Leukemia Who Failed Gleevec^®

8 JUN 2010　[Pharmaceuticals]

• SPRYCEL^® (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec^® in Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

7 JUN 2010　【Pharmaceuticals】

• Otsuka Pharmaceutical to Introduce 1,300 iPad™ Units for Use as Multifunctional Pharmaceutical Information Tools

7 JUN 2010　【Consumer Products】

• A new style of “thoughtful gesture” Pocari Sweat Heartfelt Summer Letter Available at Post Offices throughout Japan from June 15

31 MAY 2010　[Pharmaceuticals]

• Streptococcus pneumoniae Kit "RAPIRUN Pneumococcus" Approval obtained as in vitro diagnostic on May 26

26 MAY 2010　【Corporate】

• Indonesian affiliate PT. Amerta Indah Otsuka hosts May 26, 2010 dedication ceremony for Kejayan Factory - New Pocari Sweat production facility -

10 MAY 2010　【Consumer Products】

• Nature MadeR Essential Nutrients for Modern Life Stlyes Introducing New Family Size Versions of Iron & Fish Oil（with EPA & DHA） Available from May 11, 2010

26 APR 2010　【Corporate】

• Core of Global Basic Research Drug Discovery Research Building "10th Research Center" Completed on April 26

23 APR 2010　【Pharmaceuticals】

• First Antithrombotic Orally Disintegrating Tablets Antiplatelet Agent "Pletaal^® OD Tablets" Launched on April 26

23 APR 2010　【Corporate】

• Otsuka Pharmaceutical to Exhibit Soylution Concept Video in Japan Industry Pavilion at Expo 2010 Shanghai

20 APR 2010　【Consumer Products】

• A Refreshing New Concept: Whole Soy + Carbonate Sparkling Soy Water, SOYSH Debuts

08 APR 2010　【Pharmaceuticals】

• Groundbreaking Ceremony for New Plant to Manufacture Active Pharmaceutical Ingredients held on April 8 at Saga Factory

31 MAR 2010　[Corporate]

• First reader-participation collaboration OTSUKA Health Comic Library Sequel Vol. 3 “We Are Children of the Earth: The Environment & Our Health” March 31 publication for donation to elementary schools nationwide

17 MAR 2010　[Pharmaceuticals]

• Otsuka Pharmaceutical and Acucela Receive FDA Fast Track Designation for ACU-4429 in Patients with Dry AMD

12 MAR 2010　[Pharmaceuticals]

• FerriSeltz^® powder 20%, MRI Oral GI Contrast Agent, Receives Additional Approval for GI Negative Imaging in Cholangiopancreatography

11 MAR 2010　[Pharmaceuticals]

• Rapid Assay Kit for RS virus, QUICKNAVI^™-RSV, Launch on April 6

8 MAR 2010　[Pharmaceuticals]

• In-vitro Diagnostic Kit, WT1 mRNA Assay Kit "Otsuka" Application Filed for Additional Purpose of Use with Myelodysplastic Syndromes

5 MAR 2010　[Consumer Products]

• New Medicated Skin Wash from UL•OS Line of Men's Face & Body Care Available from April 22, 2010

1 MAR 2010　[Pharmaceuticals]

• The Results of CSPS II, a Large-scale Clinical Trial of Cilostazol in Preventing Recurrent Strokes, Presented at American Stroke Association's International Stroke Conference on February 26

25 FEB 2010　[Consumer Products]

• French Health Food Brand Gerblé to Debut in Japan Made from rigorously selected natural ingredients in southern France Test Marketing Begins April 6, 2010

28 JAN 2010　[Consumer Products]

• InnerSignal UV Protect Make-up Base b Will Be Launched on March 1, 2010

26 JAN 2010　[Corporate]

• Otsuka Pharmaceutical Co., Ltd. and Fuso Pharmaceutical Industries, Ltd. Conclude Agreement for the Manufacturing and Commercialization of Therapeutic Cancer Vaccine, OTS102